advertisement
Broadway DC 7
Showing records 1 to 7 | Display all abstracts from Broadway DC60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Garway-Heath DF
Lancet 2015; 385: 1295-1304
60369 Hydrostatic pressure does not cause detectable changes in survival of human retinal ganglion cells
Osborne A; Aldarwesh A
PLoS ONE 2015; 10: e0115591
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Crabb DP; Bunce C
Lancet 2015; 385: 1295-1304
60369 Hydrostatic pressure does not cause detectable changes in survival of human retinal ganglion cells
Rhodes JD; Broadway DC
PLoS ONE 2015; 10: e0115591
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Lascaratos G; Amalfitano F
Lancet 2015; 385: 1295-1304
60369 Hydrostatic pressure does not cause detectable changes in survival of human retinal ganglion cells
Everitt C; Sanderson J
PLoS ONE 2015; 10: e0115591
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Anand N; Azuara-Blanco A; Bourne RR; Broadway DC; Cunliffe IA; Diamond JP; Fraser SG; Ho TA; Martin KR; McNaught AI; Negi A; Patel K; Russell RA; Shah A; Spry PG; Suzuki K; White ET; Wormald
Lancet 2015; 385: 1295-1304
